Şunu aradınız:: subcutaneous (Danca - İspanyolca)

subcutaneous insulin i er
exubera insulina subcutánea co

subcutaneous insulin i kk er
exubera insulina subcutánea n co

anvendelsesmÅde og indgivelsesvej( e) subcutaneous use
forma y vÍa(s) de administraciÓn co

core spc for human normal immunoglobulin for subcutaneous and intramuscular use
core spc for human normal immunoglobulin for subcutaneous and intramuscular use

titel på dokumentet note for guidance on the clinical investigation of human normal immunoglobulin for subcutaneous and intramuscular use
título del documento note for guidance on the clinical investigation of human normal immunoglobulin for subcutaneous and intramuscular use

core spc for human plasma derived antithrombin note for guidance on the clinical investigation of human normal immunoglobulin for subcutaneous and intramuscular use
core spc for human plasma derived antithrombin note for guidance on the clinical investigation of human normal immunoglobulin for subcutaneous and intramuscular use

titel på dokumentet note for guidance on the clinical investigation of plasma derived antithrombin products core summary of product characteristics for plasma- derived antithrombin products note for guidance on the clinical investigation of human normal immunoglobulin for intramuscular and subcutaneous use core summary of product characteristics for human normal immunoglobulin for intramuscular and subcutaneous use note for guidance on the clinical investigation of plasma derived fibrin sealants core summary of product characteristics for plasma derived fibrin sealants note for guidance on the clinical investigation of von willebrand factor core summary of product characteristics for von willebrand factor note for guidance on the clinical investigation of alpha1 antitrypsin core summary of product characteristics for alpha1 antitrypsin core summary of product characteristics for the following specific immunoglobulins:
título del documento note for guidance on the clinical investigation of plasma derived antithrombin products core summary of product characteristics for plasma-derived antithrombin products note for guidance on the clinical investigation of human normal immunoglobulin for intramuscular and subcutaneous use core summary of product characteristics for human normal immunoglobulin for intramuscular and subcutaneous use note for guidance on the clinical investigation of plasma derived fibrin sealants core summary of product characteristics for plasma derived fibrin sealants note for guidance on the clinical investigation of von willebrand factor core summary of product characteristics for von willebrand factor note for guidance on the clinical investigation of alpha1 antitrypsin core summary of product characteristics for alpha1 antitrypsin core summary of product characteristics for the following specific immunoglobulins: